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Abstract
Background: Structural and non-structural substitutes of autologous bone grafts are frequently used in hindfoot
arthrodeses and osteotomies. However, their efficacy is unclear.
The primary goal of this systematic review was to compare autologous bone grafts with structural and
non-structural substitutes regarding the odds of union in hindfoot arthrodeses and osteotomies.
Methods: The Medline and EMBASE and Cochrane databases were searched for relevant randomized and
non-randomized prospective studies as well as retrospective comparative chart reviews.
Results: 10 studies which comprised 928 hindfoot arthrodeses and osteotomies met the inclusion criteria for this
systematic review. The quality of the retrieved studies was low due to small samples sizes and confounding
variables. The pooled random effect odds for union were 12.8 (95% CI 12.7 to 12.9) for structural allografts, 5.7 (95%
CI 5.5 to 6.0) for cortical autologous grafts, 7.3 (95% CI 6.0 to 8.6) for cancellous allografts and 6.0 (95% CI 5.7 to 6.4)
for cancellous autologous grafts. In individual studies, the odds of union in hindfoot arthrodeses achieved with
cancellous autologous grafts was similar to those achieved with demineralised bone matrix or platelet derived
growth factor augmented ceramic granules.
Conclusion: Our results suggest an equivalent incorporation of structural allografts as compared to autologous
grafts in hindfoot arthrodeses and osteotomies. There is a need for prospective randomized trials to further clarify
the role of substitutes of autologous bone grafts in hindfoot surgery.
Background
Hindfoot arthrodeses and osteotomies are performed to
treat various pathologies such as posterior tibial tendon
insufficiency [1-3], hindfoot osteoarthritis [4-6] and de-
formities related to posttraumatic conditions [7,8] and
neuromuscular disease [9,10]. In these procedures, struc-
tural (cortical) autologous bone grafts and substitutes
are used when an open wedge osteotomy or an interpos-
ition arthrodesis is performed to provide mechanical
support in the resulting bone gap. On the other hand,
non-structural (cancellous) bone grafts and substitutes
are utilized for in situ arthrodesis with the intention to
promote bone healing.
The hindfoot is a challenging environment for bone
healing due to mechanical loading, restricted blood sup-
ply and thin soft tissue coverage. Non-unions are
observed in up to 14% [11-14] of patients undergoing
hindfoot fusions and osteotomies and even more fre-
quently in patients with impaired bone healing, such as
diabetics and smokers [4,15,16]. Implanted structural
bone grafts may also show collapse under load with
consecutive loss of deformity correction [17]. Both, non-
union and graft collapse may lead to unsatisfactory out-
comes [12,18]. Therefore, the selection of an appropriate
bone graft able to withstand these challenges is import-
ant in hindfoot arthrodeses and osteotomies.
From a biological standpoint autologous grafts are an
excellent choice. They incorporate quickly due to
favourable osteoconductivity [19-21] and osteoinductiv-
ity [22] as well as potential osteogenicity [20,23].
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ance [24]. However, the use of autologous grafts is lim-
ited by associated donor site morbidity [25], increased
surgery time and finite availability [26-28]. These limita-
tions incline surgeons to use substitutes for autologous
bone grafts. Allografts are commonly the first option
with similar osteoconductivity and osteoinductivity as
compared to autologous grafts [29], but they carry the
risk of transmitting infectious diseases [30] and may in-
cite an immunological response [31,32] leading to
impaired graft incorporation [33,34] and secondary graft
collapse [35]. Further processing of allografts using
freeze drying techniques and treating the graft with
hypotonic solutions, acetone, ethylenoxide or gamma ir-
radiation can eliminate cellular and viral particles and
thus can lower the risk of infectious disease transmission
[36-38]. These acellular allografts preserve their osteo-
conductive properties but studies showed that their
mechanical strength and osteointegration may be
affected by this process [39].
Alternatively, allografts can be decalcified to extract
demineralized bone matrix (DBM) which is known to
have osteoinductive and partly osteoconductive proper-
ties [40]. However, the osteoinductivity of DBM depends
on multiple factors including the manufacturing process
[41,42] and the donor [43]. More consistent characteris-
tics may be expected from synthetic substitutes of au-
tologous grafts. Current market options range from
very brittle ceramics (made from hydroxapatite [HA]
or tricacliumphosphate [TCP]) that have favourable
osteoconductive properties [44] to more resistant
osteoconductive metals such as tantalum [45] as well
as costly recombinants of bone morphogenetic pro-
teins (BMPs) [46] and platelet derived growth factors
(PDGFs) [47].
Nonetheless, the choice between autologous grafts and
different substitutes should not only be based on bio-
logic and biomechanical considerations, but also on the
best evidence available in the literature. Thus, the pri-
mary goal of this systematic review was to assess the ef-
ficacy of autologous bone grafts and their structural and
non-structural substitutes to achieve union in hindfoot
arthrodeses and osteotomies. As a secondary goal, we
aimed to compare the resistance of structural grafts to
collapse in these hindfoot procedures.
Methods
Search strategy
We conducted an electronic search of Medline, the
Cochrane Library, and EMBASE from inception of each
database to December 2011 for randomized and non-
randomized, controlled studies on the use of structural
and non-structural autologous bone grafts and substi-
tutes in hindfoot osteotomies and arthrodeses. We used
“bone transplantation”, “allograft”, “xenograft”, “synthetic
bone graft”, “beta tricalcium phosphate”,”hydroxyapa-
tite”, “bone morphogenetic protein”, “demineralized
bone matrix”, “foot” as terms or medical subject head-
ings. There were no restrictions with respect to language
or date of publication.
Studies eligible for this systematic review had to com-
pare cortical or cancellous autologous bone grafts with
any structural or non-structural substitute in patients
undergoing subtalar, talonavicular, triple arthrodesis or
lateral column lengthening. Only prospective or retro-
spective, controlled trials with a minimum sample size
of 20 patients were eligible for inclusion. All titles and
abstracts identified by our search were reviewed by two
orthopedic surgeons independently (AF, AMM). If either
reviewer deemed an abstract potentially eligible, the full
text of that article was obtained and assessed for eligibil-
ity by both reviewers. Disagreement was resolved by dis-
cussion or consultation with the senior author.
Two reviewers independently extracted patient demo-
graphics, operative data, and outcome data from each
article. The primary outcome data comprised of rate of
union. Secondary outcome data referred to the occur-
rence of graft collapse either defined as an obvious disin-
tegration of the graft or measured indirectly by a loss of
hind- and/or midfoot alignment. In addition, time-to-
union was recorded.
Quality assessment of retrieved studies
The methodological quality of included studies was in-
dependently assessed by two reviewers (AMM, AM).
Randomized controlled trials were assessed based on
concealment of treatment allocation, blinding of out-
come assessors, completeness of follow-up, and the at-
tainment of sufficient power to detect significant
differences. The Newcastle-Ottawa Quality assessment
scale [48] was used for the quality assessment of non-
randomized studies. In this context, the included studies
were evaluated according to three main categories, i.e.
“selection”, “comparability” and “outcome”. Each of
these categories comprised several evaluation criteria:
Within the category “selection”, each study was assessed
regarding the representativeness of the (1) exposed and
the (2) unexposed study cohort and (3) the ascertain-
ment of exposure to the surgical procedure and graft of
interest. It was also verified whether (4) the outcome of
interest was absent at the beginning of the study. Within
the category “comparability”, it was assessed if the study
controlled for confounding variables. Within the cat-
egory “outcome”, each study was tested for (1) blinded
or record linked outcome assessment and (2) complete-
ness of follow-up (i.e. a documented follow-rate ≥ 80%).
It was also assessed if (3) the follow-up time was long
enough to detect the outcome of interest.
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three main categories with each star representing a ful-
filled evaluation criterion. A maximum of two stars
could be allotted to the category “comparability”.
Statistical analyses
Data for the primary endpoint rate of union could be
gathered from all but one included study. Using these
data, the odds for union were calculated for structural
and non-structural autologous grafts and allografts, in-
dependently. For data synthesis, odds were pooled using
inverse variance weights in a fixed effects model, and
assessed for mathematical between-study heterogeneity
using Q statistic. The cut-off was set at a p-value of 0.1
to account for loss of power due to small sample sizes.
In case of significant mathematical heterogeneity, the
DerSimonian-Laird random effects model [49] was used.
This method allows for between-study heterogeneity as-
suming that the individual study results are different,
but normally distributed around a common, pooled ef-
fect. We used Egger’s regression [50] to test for publica-
tion bias.
Since data were collected by type of graft and not by
study, the odds rather than the odds ratio are given. All
results are given as odds with the 95% confidence inter-
val (CI). All calculations were done with intercooled
STATA 12 (StataCorp LP, College Station, Tx).
Results
Literature search
Our online search produced 403 articles in total. After
exclusion of duplicates and studies without a control group,
10 studies met our eligibility criteria (Figure 1). Among the
ten included studies, seven compared structural autologous
bone grafts with substitutes (Table 1). One randomized
controlled trial [51] and two retrospective chart reviews
[52,53] compared structural allografts with autologous
grafts in Evan’s osteotomies of the calcaneus. Another three
retrospective chart reviews [17,54,55] compared structural
allografts with autologous grafts in mixed patient popu-
lations that comprised both hindfoot arthrodeses and
osteotomies. A subgroup analysis in a retrospective chart
review [4] compared structural allografts with autologous
grafts in isolated hindfoot arthrodeses.
Four studies on non-stru bone grafts met our inclusion
criteria (Table 2) which all included subjects undergoing
hindfoot fusions. There was one randomized controlled
trial comparing recombinant PDGF augmented ceramic
granules with cancellous autologous grafts [56]. In a pro-
spective controlled study [57], DBM was compared with
cancellous autologous grafts. The remaining two retro-
spective chart reviews [4,58] compared cancellous allografts
and no graft application with cancellous autologous grafts.
In nine [4,51-58] of the ten included studies rate of
union was used as an outcome measure to compare au-
tologous grafts with structural or non-structural substi-
tutes. In all of these nine studies union was defined on
the basis of plain radiography or conventional tomog-
raphy as a bridging trabeculation across the osteotomy
gap or arthrodeses site. Two studies [51,57] used ab-
sence of pain at the surgical site as an additional criter-
ion for union. In only one study [56] healing was
additionally assessed using computed tomography (CT)
with union defined as a continuity of the trabecular lines
within 50% of the (joint) space to be bridged.
In four [17,51,53,54] of the ten included studies graft
collapse was used as primary or secondary outcome meas-
ure. All of these studies compared structural allografts
Figure 1 Study flow diagram.
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Ref. Methodology Results Quality
Structural allografts versus cortical autologous grafts in hindfoot OTs
Dolan et al.[ 51] Randomized controlled trial Rate of union at 8 weeks No concealed allocation No blinded outcome
assessment 100% FU Underpowered study
18 freeze-dried structural allografts vs. 15 cortical autologus grafts in 31 adults
undergoing Evan’s OTs. FU: 8 and 12 weeks
Allografts: 17/18 (94%)
Autologous grafts: 9/15 (60%), P = 0.03
Rate of union at 12 weeks
100% for allografts and autologous
grafts
No graft collapse in both groups
Templin et al.[ 52] Retrospective comparative chart review (1994–2003) Rate of union Selection: ***
Allografts: 27/30 (90%) Comparability:
30 freeze-dried structural allografts vs 5 structural autologous grafts in 35 children
undergoing Evan’s OTs. Mean FU 3.6 years (range 6–12 years)
Autologous grafts: 4/5 (80%) Outcome: *
P = n. s.
Kwak et al.[ 53] Retrospective comparative chart review (2000–2005) Talo-1
st metatarsal, talo-calcaneal
and calcaneal pitch angle at final FU
Selection: ***
Comparability:
118 acellular allografts (Tutoplast
W) vs. 10 structural autologous grafts in 79 children
undergoing Evan’s OTs. Mean FU 15 months (range 13-21months)
No significant difference between the
two graft types
Outcome: *
Structural allografts versus cortical autologous grafts in hindfoot ADs
Easley et al.[ 4] Subgroup comparison in a retrospective chart review (1988–1995) Rate of union Selection: ***
Allografts: 2/5 (40%) Comparability:
5 structural allografts vs. 29 structural autologous grafts in isolated subtalar ADs. Mean
FU 51 months (range 24–130 months)
Autologous grafts: 24/29 (83%) Outcome: *
P = n.s.
Time to union
Autologous grafts: 16 weeks (10-30
weeks)
P = n. s.
Structural allografts versus cortical autologous grafts in miscellaneous procedures (hindfoot ADs/OTs)
Grier et al. [54] Retrospective comparative chart review (1996–2006) Rate of union Selection: **
Allografts + PRP: 29/31 (94%) Comparability:
31 structural freeze-dried allografts + PRP vs. 20 structural autologous grafts in 18 adult
Evan’s OTs and 33 adult CC ADs. Mean FU: 20 months (range 3-72 months)
Autologous grafts: 14/20 (70%) Outcome: *
P = 0.045
Improvement of the talo-1
st
metatarsal and calcaneal pitch angle
No significant difference between the
two graft types
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9Table 1 Studies comparing structural autologous bone grafts with substitutes in hindfoot arthrodeses and osteotomies (Continued)
Danko et al.[ 17] Retrospective comparative chart review (1990–1992) Graft collapse Selection: ***
Evan’sO T : Comparability:
7 structural allografts vs 33 structural autologous grafts in 69 pediatric Evan’s OTs and
61 pediatric CC ADs. Mean FU 2.5 years (range 0.6-7.8 years)
Allografts: 0/39 Outcome: ***
Autologous grafts 0/30
P=?
CC ADs:
Allografts: 17/58 (29%)
Autologous grafts: 0/3 (0%)
P=?
Mahan et al. [55] Retrospective comparative chart review (1977–1990) Rate of union Selection: **
Allografts: 198/215 Comparability:
215 freeze dried allografts vs 85 autologous grafts in 153 OTs, 55 ADs, 82 other
procedures. Minimum FU 6 weeks
(92%) Outcome: *
Autologous grafts: 78 /85 (92%),
P = n. s.
Rate of delayed union
Allografts: 8/215 (4%)
Autologous grafts 2/85 (2%)
P = n. s.
Abbreviations: CC=calcaneocuboideal, OTs= osteotomies, ADs= arthrodeses, FU = follow-up, n.s.= not significant.
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9Table 2 Studies comparing non-structural autologous bone grafts with substitutes in hindfoot arthrodeses and osteotomies
Ref. Methodology Results Quality
Cancellous allografts versus cancellous autologous grafts in hindfoot ADs
McGarvey et al. [58] Retrospective comparative chart review (1990–1992) Rate of union Selection: ***
Allografts: 21/24 (88%) Comparability:
24 acellular allograft chips vs 17 cancellous autologous grafts in 37 subtalar, double
and triple ADs. FU: Minimum 18 months
Autologous grafts: 16/17
(94%)
Outcome:*
P=?
Time-to- union
Triple/Double/Subtalar AD
Allografts: 4.0/4.0/4.1 months
Autologous grafts 3.0/3.2/3.6
months
P= n. s
Easley et al. [4] Subgroup comparison in a retrospective chart review (1988–1995) Rate of union Selection: **
Allografts: 14/17 (82%) Comparability:
17 cancellous allograft vs. 94 cancellous autologous grafts in subtalar ADs. Mean FU
51 months(range: 24–130 months)
Autologous grafts: 80/94
(85%)
Outcome:*
P= n. s.
Time –to- union
Allografts: 13 weeks
(10–24 weeks)
Autologous grafts: 11weeks
(8–20 weeks)
P= n. s
DBM versus cancellous autologous grafts in hindfoot ADs
Michelson et al.
[57]
Prospective comparative study (1990–1993) Rate of union Selection: ***
37 DBM vs.18 cancellous autologous grafts in 11 subtalar AD’s, and 44 triple AD’s
FU: Until complete healing
DBM: 36/37 (97%) Comparability:
Autologous grafts: 16/18
(89%)
Outcome:***
P= n. s.
Time –to-union
DBM: 3.0 – 3.4 months
Autologous grafts 2.7-3.7
months
P=n. s.
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9Table 2 Studies comparing non-structural autologous bone grafts with substitutes in hindfoot arthrodeses and osteotomies (Continued)
No graft versus cancellous autologous grafts in hindfoot ADs
Easley et al.[ 4] Subgroup comparison in a retrospective chart review (1988–1995) Rate of union Selection: **
No graft: 34/39 (87%) Comparability:
39 “no graft” vs 94 cancellous autologous grafts in isolated subtalar ADs. Mean FU
54 months (range: 24–130 months)
Autologous grafts: 80/94
(85%)
Outcome:*
P= n. s.
Time-to-union
No graft: 11w (8–24)
Autologous grafts: 11weeks
(8–20 weeks)
P= n. s
Synthetic bone grafts versus cancellous autologous grafts in hindfoot ADs
DiGiovanni et al.
[56]
Randomized controlled trial (2006/7) Rate of X ray based union
at 6-12-36 weeks:
No concealed allocation Blinded outcome assessment 80-
93% follow-up Underpowered study
14 PDGF augmented ß-TCP (Augment
W) vs 6 cancellous autologous grafts in 20
adult subtalar, triple, ankle ADs. FU:6, 12 and 36 weeks PDGF/ß-TCP:
0/11(0%)-5/12(42%)-10/13
Autologous grafts:
0/4 (0%)-1/3 (33%)-3/5 (60%)
P= ?
Rate of CT based union at
6–12 weeks
PDGF/ß-TCP:
5/13 (38%)-9/13% (69%)
Autologous grafts:
2/5 (40%)- 3/5 (60%)
P= ?
Abbreviations: OTs= osteotomies, ADs= arthrodeses, FU= follow-up, n.s.= not significant.
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9with autologous grafts in pediatric [17,53] or adult [51,54]
lateral column lengthening procedures. Graft collapse was
defined on plain radiographs either directly as obvious
graft disintegration [17,51] or indirectly based on the asso-
ciated change of the talo-first metatarsal, talo-calcaneal
and calcaneal pitch angle [53,54].
The quality of retrieved studies is summarized in
Table 1 and 2. In brief, all studies had small sample sizes
at least in one group and thus limited capacity to detect
significant differences. In bothr a n d o m i z e dc o n t r o l l e dt r i a l s ,
patient allocation was not concealed and only in the trial
by DiGiovanni et al. [56] outcomes were assessed by
blinded observers. All non-randomized trial did not con-
trol for confounding factors.
Rate of union: structural autologous grafts and allografts
D a t ac o u l db ea b s t r a c t e df o r1 5 4i m p l a n t e ds t r u c t u r a l
autologous grafts. The pooled, fixed effects odds of union
across all studies for structural autologous grafts was 6.5
(95% CI 6.0 to 7.0), but showed significant heterogeneity
(p<0.001). Using the DerSimonian-Laird random effects, we
calculated the pooled odds of union for autologous grafts to
be 5.7 (95% CI 5.5 to 6.0), which is significantly different
from no effect (or odds of 1) at a p-value of less than 0.001.
There was no evidence for publication bias (p=0.678).
For structural allografts, we could collect data on 299
cases. The pooled, fixed effects odds for union were 14.5
(95% CI 14.0 to 14.0), but again with significant hetero-
geneity (p<0.001). The random effects odds were 12.8
(95% CI 12.7 to 12.9), which is significantly different from
no effect (or odds of 1) at a p-value of less than 0.001.
There was some evidence for publication bias (p=0.037),
suggesting overestimated odds.
The direct comparison of structural autologous grafts
and allografts show that the 95% confidence intervals for
union do not overlap, which is indicative of a significant
difference.
Rate of union: non-structural autologous grafts and
allografts
In order to quantitatively assess the rate of union for non-
structural autologous grafts, data were abstracted from
228 hindfoot fusions. The pooled fixed odds for union
were 6.0 (95% CI 5.7 to 6.4). Again, there was significant
heterogeneity (p<0.001). The random effects odds were
7.3 (95% CI 6.0 to 8.6), again significantly different from
no effect (or odds of 1) with a p-value of less than 0.001.
There was no evidence for publication bias (p=0.291).
For non-structural allografts, data from only 41 hind-
foot fusions from two studies [4,58] could be included
into analysis. The pooled fixed odds for union were 5.9
(95% CI 5.0 to 6.7) with again significant heterogeneity
(p=0.016). The random effect odds for union with non-
structural allografts were 5.8 (95% CI 4.4-7.3).
Rate of union: other non-structural grafts
For the remaining non-structural grafts data could only
be obtained a single study. For these graft types odds
for union were calculated based on the individual study
results. The odds of union were 6.8 (95% CI 5.9 to 7.7)
for patients receiving no graft, 8.0 (95% CI 6.5 to 9.5) for
patients receiving DBM and 3.7 (95% CI 2.4 to 5.0) for
patients receiving PDGF/ß- TCP.
Graft collapse
In all four studies with graft collapse as an outcome meas-
ure the use of structural allografts was not associated with a
significantly increased graft disintegration or loss of midfoot
alignment as compared to structural autologous grafts.
Discussion
The primary goal of this systematic review was to review
the evidence for the efficacy of structural and non-
structural autologous bone grafts and substitutes with
respect to rate of union in hindfoot osteotomies and
arthrodeses.
We acknowledge several limitations of this study. We
pooled data from two different procedures- hindfoot oste-
otomies and arthrodeses- which may raise concerns from
a methodological point of view. However, from a bio-
logical standpoint, arthrodeses and osteotomies are very
similar situations since in both procedures the bone graft
is placed in between fresh bleeding osseous surfaces. We
also found major methodological limitations in all studies
included in this review. Particularly, small sample sizes
and confounding variables were major points of criticism
which makes the direct comparison of different grafts
types difficult. Therefore, we decided not to report odds
ratios, but odds for the rate of union achieved with the in-
dividual graft types. In addition, all studies except two
[56,58] assessed the presence of bony healing on the basis
of plain radiographs which are limited in studying the
bony consolidation within the complex anatomy of a fused
hindfoot joint or a three dimensional osteotomy [12,59].
The rates of union which were assessed with the use of
plain radiography might have been overestimated [12].
The quantitative data analysis performed in this sys-
tematic review suggests that structural allografts may be
effective substitutes for autologous grafts in these pro-
cedures. The pooled random effect odds for union with
structural allografts were 12.8 (95% CI 12.7 to 12.9) and
thus even higher than those calculated for structural
autologous grafts (i.e. 5.7 [95% CI 5.5 to 6.0]). Never-
theless, the limited quality of the underlying evidence
as well as the presence of publication bias may have
both inflated the odds for union in the allograft group.
However, it is unlikely that more extensive and reliable
evidence would change the odds of union for structural
allografts to a value which is substantially below that of
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gest an equivalent incorporation of structural allografts
as compared to autologous grafts. This conclusion from
our quantitative data analysis may further be supported
by the fact that the pooled odds for union for cancel-
lous allografts were also very similar to those calculated
for cancellous autologous grafts.
One randomized controlled trial [17] and three retro-
spective chart reviews [17,52,53] also showed no increased
risk for graft collapse when allografts were used instead of
autologous grafts in Evan’s osteotomies, but these data
were mainly generated in pediatric studies and thus defini-
tively require further verification in a broad adult patient
population.
Furthermore, the individual data from one prospective
study [51] and from one small randomized controlled trial
[57] indicated that DBM and PDGF augmented ß-TCP
ceramic granules could potentially substitute for cancel-
lous autologous grafts in hindfoot fusions. Nonetheless,
with the lack of prospective studies with sound method-
ology, it currently remains unclear if the use of cancellous
autologous bone grafts and substitutes is effective in pro-
moting bony healing in arthrodeses of the hindfoot.
To our knowledge, this is the first systematic review
on structural and non-structural bone grafts in hindfoot
surgery, although many narrative reviews have already
been published on this topic [46,60-63]. These narrative
reviews mainly focused on the biologic properties of these
grafts and did not synthesize results from different studies.
On the other hand, there are several systematic reviews
and meta-analyses on structural and non-structural autolo-
gous bone grafts and substitutes in spine surgery [64-70].
These studies showed conflicting results on the osteointe-
gration of structural allografts. In one meta-analysis [70],
structural allografts were associated with a higher fre-
quency of graft collapse and non-union as compared to
autologous grafts, but more recent meta-analysis [66]
does not confirm these results.
Conclusion
The current evidence suggests that structural allografts
appear to be at least non-inferior to autologous grafts in
respect to the odds for union in hindfoot arthrodeses and
osteotomies. Considering the large number of bone grafts
and substitutes used in hindfoot osteotomies and arthrod-
eses [71], there is an urgent need for well-designed rando-
mized controlled trials to assess the efficacy of structural
and non-structural autologous bone grafts substitutes.
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